Close icon
Two crossed lines that form an X . It indicates a way to close an interaction, or dismiss a notification. Verily Chief Medical Officer Jessica Mega as JDRF LA s IMAGINE Gala to benefit type 1 diabetes research at The Beverly Hilton on May 14, 2016. Todd Williamson/Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Verily has hired a chief marketing officer and chief information officer as it continues to expand its leadership team.
The new hires come amidst a reshuffling of top brass and follow a turbulent 2020 that saw an exodus of talent.
Google
Verily has seen 24 departures by top talent in the past year.
2020 brought hiccups like repurposing Verily for the pandemic, which employees said was exhausting.
Now the upstart has restructured its leadership team as it plots a major expansion.
Verily, an Alphabet life sciences company, has had a string of exits among top brass in recent months.
Thomas Stanis, one of Verily s cofounders, and Ashraf Hanna, the chief operations officer, left in February 2020 and November 2020, respectively. Hanna joined testing company Genalyte as CEO, and Stanis founded a startup with a Verily colleague, Nikhil Roy, that s focused on fixing disconnected speciality care.
Broad, Verily take Terra bioinformatics platform to Microsoft Azure cloud
Modern Healthcare
Print
The Broad Institute, Verily Life Sciences, and Microsoft on Monday announced a strategic partnership to extend the Terra bioinformatics analysis platform to the Microsoft Azure cloud.
The cloud-based Terra platform was codeveloped by the Broad and Google sibling Verily Life Sciences. By offering it on Azure, the three companies hope that they can improve collaboration among many of the 168,000 data scientists, biomedical researchers, and clinicians who use Terra. This partnership combines multimodal data, secure analytics, and scalable cloud computing to improve insight and evidence generation, allowing us to ultimately impact more patients lives, Verily COO Stephen Gillett said in a statement.
Jan 11, 2021 10:58am Microsoft plans to dedicate its own software engineering resources and lend its machine learning expertise to Terra’s efforts, while also using open application interfaces and internationally recognized modular software components. (Microsoft)
Verily and the Broad Institute of MIT and Harvard hope to dramatically boost the reach of their open-source biomedical research platform through a new partnership with Microsoft.
The scalable Terra platform includes digital tools currently used by over 15,600 researchers, to analyze and collaborate on data gathered from nearly 2 million study participants spanning cancer genomics to infectious disease projects.
Now, Microsoft is signing on as an equal partner in Terra’s operation and development and the computing giant plans to help drive its global adoption, by pulling it through its established network of AI and cloud-computing customers that includes over 168,000 healthcare organizations.
Jan. 11, 2021 On Monday, Broad Institute of MIT and Harvard, Verily, an Alphabet company, and Microsoft Corp. announced a strategic partnership to accelerate new innovations in biomedicine through the Terra platform. Terra, originally developed by Verily and the Broad Institute, is a secure, scalable, open-source platform for biomedical researchers to access data, run analysis tools and collaborate. Terra is actively used by thousands of researchers every month to analyze data from millions of participants in important scientific research projects. Biomedical data are being generated and digitized at a historic rate and are expected to reach dozens of exabytes by 2025 including data from genomics, medical imaging, biometric signals and electronic health records. Coupled with powerful research and analysis tools, these datasets can provide lifesaving insights into some of the world’s most pressing health issues. But making use of these important datasets remains difficul